期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effect of kangxianling on hepatic fibrosis in murine schistosomiasis
1
作者 杨运高 郭振球 +2 位作者 袁肇凯 郭绶衡 黄献平 《Journal of Medical Colleges of PLA(China)》 CAS 1996年第2期84-87,共4页
The effect of kangxianling (KXL) on hepatic fibrosis resulting from schistosomiasis was investigated in mice. Murine models with hepatic fibrosis of schistosomiasis japonicum were established and killed after being tr... The effect of kangxianling (KXL) on hepatic fibrosis resulting from schistosomiasis was investigated in mice. Murine models with hepatic fibrosis of schistosomiasis japonicum were established and killed after being treated with KXL for 40 d. The experimental results showed that in the KXL group the liver weight (0. 53±0. 07 g/10g ·bw ), the hepatic fibrosis degree (0. 71±0. 19 marks),and the content of collagen ( 14. 44 ±4. 41 mg/g powder) and type III procollagen (27. 83±5. 82 ug/L) in the livers were significantly different from those of the control group (P <0 .05 or P<0.01 ). Through pathological examination,it was found that KXL could significantly soften cirrhotic liver, ameliorate hepatic swelling, and inhibit the deposition of collagen protein and proliferation of collagen fibers in the liver. These findings were analyzed for their relationship with the inhibiton of collagen synthesis, improvement of collagen degradation ,promotion of hepatic circulation and nutrition and reduction of damage to hepatocytes. The study suggested that KXL is a new effective and prospective drug for therapy of schistosomal hepatic fibrosis. 展开更多
关键词 HEPATIC FIBROSIS SCHISTOSOMIASIS kangxianling
下载PDF
The effects of Kangxianling on renal fibrosis as assessed with a customized gene chip 被引量:3
2
作者 董飞侠 张新志 +1 位作者 吴峰 何立群 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2012年第2期229-233,共5页
OBJECTIVE:To determine the mechanisms by which Kangxianling(KXL) treats renal interstitial fibrosis using a customized gene chip.METHODS:Twelve out of 18 specific pathogen-free sprague dawley(SPF SD) rats underwent a ... OBJECTIVE:To determine the mechanisms by which Kangxianling(KXL) treats renal interstitial fibrosis using a customized gene chip.METHODS:Twelve out of 18 specific pathogen-free sprague dawley(SPF SD) rats underwent a unilateral ureteral occlusion.These rats were then randomly assigned into either the model unilateral ureteral obstruction(UUO) or Kangxianling(KXL) group.The other six rats were assigned to the sham-operated group.The UUO and sham-operated groups were given normal saline via intragastric administration,whereas the KXL group was given KXL via intragastric administration.All rats were sacrificed for renal tissue collection(i.e.left nephridial tissue),and the detection of genetic changes with the customized chip.RESULTS:Compared to the sham-operated group,transforming growth factor-β1(TGF-β1),Smad2,and Smad3 genes were significantly up-regulated in the UUO group,with >1.5-fold rise(P<0.01).The Smad7 gene was significantly reduced in the UUO versus sham-operated group,with a down-regulation of >1.5-fold(P<0.01).In the KXL group,TGF-β1,Smad2,and Smad3 genes were significantly reduced compared to the UUO group,with a down-regulation of >1.5-fold(P<0.01),whereas the Smad7 gene was significantly increased compared to the UUO group,with an up-regulation of >1.5-fold(P<0.01).CONCLUSION:It was found that KXL can significantly reduce the gene levels of TGF-β1,Smad2,and Smad3.Immunohistochemistry findings also revealed significantly lower TGF-β1/Smads-mediated gene transcription activity.These findings suggest that KXL may negatively regulate the TGF-β1/Smads signal pathway to inhibit the occurrence of renal fibrosis. 展开更多
关键词 Unilateral ureteral obstruction animal model kangxianling Customized gene chip Iimmunohistochemistry Tgf-β1/smads Renal fibrosis
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部